Biological characteristics of mesenchymal stem cells;Características biológicas das células-tronco mesenquimais

Revista Brasileira de Hematologia e Hemoterapia

Volumn 31, Issue SUPPL. 1, 2009, Pages 25-35

  Bydlowski, Sergio P ^a   Debes, Adriana A ^b   Maselli, Luciana M F ^a   Janz, Felipe L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

Author keywords

Cell differentiation; Clinical applications; Markers; Mesenchymal stem cell; Stem cell

Indexed keywords

EID: 69849083361     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842009005000038     Document Type: Review

References (94)

1. Lemischka IR. Stem cell biology: A view toward the future. Ann N Y Acad Sci. 2005;1044:132-8.
2. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: Entity or function? Cell. 2001;105(7):829-41.
3. Fodor WL. Tissue engineering and cell based therapies, from the bench to the clinic: The potential to replace, repair and regenerate. Reprod Biol Endocrinol. 2003;1:102.
4. Abdallah BM, Kassem M. Human mesenchymal stem cells: From basic biology to clinical applications. Gene Ther. 2008;15 (2):109-16.
5. Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics. 2007;8:70.
6. Park KS, Lee YS, Kang KS. In vitro neuronal and osteogenic differentiation of mesenchymal stem cells from human umbilical cord blood. J Vet Sci. 2006;7(4):343-8.
7. Hashimoto J, Kariya Y, Miyazaki K. Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332). Stem Cells. 2006;24(11): 2346-54.
8. De Gemmis P, Lapucci C, Bertelli M, Tognetto A, Fanin E, Vettor R, et al. A real-time PCR approach to evaluate adipogenic potential of amniotic fluid-derived human mesenchymal stem cells. Stem Cells Dev. 2006;15(5):719-28.
9. Anisimov SV, Christophersen NS, Correia AS, Li JY, Brundin P. NeuroStem Chip: A novel highly specialized tool to study neural differentiation pathways in human stem cells. BMC Genomics. 2007;8:46.
10. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA. 2005;102(32):11474-9.
11. Abdallah BM, Kassem M. Human mesenchymal stem cells: From basic biology to clinical applications. Gene Ther. 2008;15(2):109-16.
12. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med. 2004;8(3):301-16.
13. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: Characteristics and clinical applications. Folia Histochem Cytobiol. 2006;44(4):215-30.
14. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-5.
15. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106(6):984-91.
16. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells. Regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007;9(1):204.
17. a ed. Editora Guanabara Koogan, Rio de Janeiro, RJ. Pp.131-137, 2005
18. Wagers AJ, Christensen JL, Weissman IL. Cell fate determination from stem cells. Gene Ther. 2002;9(10):606-12.
19. Knoblich JA. Asymmetric cell division during animal development. Nat Rev Mol Cell Biol. 2001;2(1):11-20.
20. Gibbons RJ. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum Mol Genet. 2005;14 Spec No 1:R85-92.
21. Sakashita K, Koike K, Kinoshita T, Shiohara M, Kamijo T, Taniguchi S, et al. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development. J Clin Invest. 2001;108(8):1195-204.
22. Strauer BE, Brehm M, Zeus T, Bartsch T, Schannwell C, Antke C, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: The IACT Study. J Am Coll Cardiol. 2005;46(9):1651-8.
23. Klein HM, Ghodsizad A, Marktanner R, Poll L, Voelkel T, Mohammad Hasani MR, et al. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum. 2007;10(1):E66-9.
24. Donmez A, Zoghi M, Cagirgan S, Acarlar C, Tombuloglu M. The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells. Transfus Apher Sci. 2006;34(3):245-51.
25. Panepucci RA, Siufi JL, Silva WA Jr, Proto-Siquiera R, Neder L, Orellana M, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells. 2004;22(7):1263-78.
26. Soukup T, Mokrý J, Karbanová J, Pytlík R, Suchomel P, Kucerová L. Mesenchymal stem cells isolated from the human bone marrow: Cultivation, phenotypic analysis and changes in proliferation kinetics. Acta Medica (Hradec Kralove). 2006;49(1):27-33.
27. Kadivar M, Khatami S, Mortazavi Y, Taghikhani M, Shokrgozar MA. Multilineage differentiation activity by human umbilical vein-derived mesenchymal stem cells. Iranian Biomed J. 2006; 10:175-84.
28. Kestendjieva S, Kyurkchiev D, Tsvetkova G, Mehandjiev T, Dimitrov A, Nikolov A, Kyurkchiev S. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int. 2008;32(7):724-32.
29. He Q, Wan C, Li G. Concise review: Multipotent mesenchymal stromal cells in blood. Stem Cells. 2007;25(1):69-77.
30. Bashey A, Donohue M, Liu L, Medina B, Corringham S, Ihasz A, et al. Peripheral blood progenitor cell mobilization with intermediatedose cyclophosphamide, sequential granulocyte-macrophagecolony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation. Transfusion. 2007;47(11):2153-60.
31. Delo DM, De Coppi P, Bartsch G Jr, Atala A. Amniotic fluid and placental stem cells. Methods Enzymol. 2006;419:426-38.
32. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, et al. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007;7:11.
33. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1):100-6.
34. Gonzalez R, Maki CB, Pacchiarotti J, Csontos S, Pham JK, Slepko N, et al. Pluripotent marker expression and differentiation of human second trimester Mesenchymal Stem Cells. Hem Biophys Res Commun. 2007;362(2):491-7.
35. Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, Buiatiotis S, et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res. 2006;16(4):329-36.
36. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001 Aug;44(8):1928-42.
37. Fickert S, Fiedler J, Brenner RE. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther. 2004;6(5):R422-32.
38. Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, et al. SHED: Stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A. 2003;100(10):5807-12.
39. Mannello F, Tonti GA. Concise review: No breakthroughs for human mesenchymal and embryonic stem cell culture: Conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells. 2007;25(7):1603-9.
40. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24(2):462-71.
41. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726-36.
42. Summer R, Fine A. Mesenchymal progenitor cell research: Limitations and recommendations. Proc Am Thorac Soc. 2008; 5 (6):707-10.
43. Sensebé L. Generation and characterization of mesenchymal stromal cells for clinical application. ISBT Science Series. 2009;4:31-6.
44. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107(11): 1395-402.
45. Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355(12): 1222-32.
46. Mazhari R, Hare JM. Mechanisms of action of mesenchymal stem cells in cardiac repair: Potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med. 2007;4 Suppl 1:S21-6.
47. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701-5.
48. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001; 98 (18):10344-9.
49. Vanderheyden M, Vercauteren S, Mansour S, Delrue L, Vandekerckhove B, Heyndrickx GR, et al. Time-dependent effects on coronary remodeling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction. Cell Transplant. 2007;16(9): 919-25.
50. Vilas-Boas F, Feitosa GS, Soares MB, Mota A, Pinho-Filho JA, Almeida AJ, et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease. Arq Bras Cardiol. 2006;87(2):159-66.
51. Arom KV, Ruengsakulrach P, Jotisakulratana V. Intramyocardial angiogenic cell precursor injection for cardiomyopathy. Asian Cardiovasc Thorac Ann. 2008;16(2):143-8.
52. Hüttmann A, Gutersohn A, Noppeney R, Neumann T, Erbel R, Dührsen U. Rapid succession of peripheral blood progenitor cell mobilization cycles in patients with chronic heart failure: Effects on the hematopoietic system. Transfusion. 2006;46 (8):1424-31.
53. Dai W, Kloner RA. Myocardial regeneration by human amniotic fluid stem cells: Challenges to be overcome. J Mol Cell Cardiol. 2007;42(4):730-2.
54. Patel AN, Sherman W. Cardiac stem cell therapy from bench to bedside. Cell Transplant. 2007;16(9):875-8.
55. van Laake LW, Hassink R, Doevendans PA, Mummery C. Heart repair and stem cells. J Physiol. 2006;577(Pt 2):467-78.
56. Raisz LG. Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. J Clin Invest. 2005;115(12):3318-25.
57. Cancedda R, Bianchi G, Derubeis A, Quarto R. Cell therapy for bone disease: A review of current status. Stem Cells. 2003;21(5):610-9.
58. Kunisaki SM, Fuchs JR, Steigman SA, Fauza DO. A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Eng. 2007;13(11):2633-44.
59. Dazzi F, van Laar JM, Cope A, Tyndall A. Cell therapy for autoimmune diseases. Arthritis Res Ther. 2007;9(2):206.
60. Brinkman DM, de Kleer IM, ten Cate R, van Rossum MA, Bekkering WP, Fasth A, et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: Long-term follow-up of a prospective clinical trial. Arthritis Rheum. 2007;56(7):2410-21.
61. Chernykh ER, Stupak VV, Muradov GM, Sizikov MY, Shevela EY, Leplina OY, et al. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med. 2007;143(4):543-7.
62. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol. 2002;174(1):11-20.
63. Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, Shintani S, et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J. 2007 Feb;71(2):196-201.
64. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R, et al. Autologous mesenchymal stem cells: Clinical applications in amyotrophic lateral sclerosis. Neurol Res. 2006;28(5):523-6.
65. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, et al. Stem cell treatment in Amyotrophic Lateral Sclerosis. J Neurol Sci. 2008;265(1-2):78-83.
66. Timmer M, Müller-Ostermeyer F, Kloth V, Winkler C, Grothe C, Nikkhah G. Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms. Exp Neurol. 2004;187(1):118-36.
67. Lindvall O. Neural transplantation: A hope for patients with Parkinson's disease. Neuroreport. 1997;8(14):Iii-x.
68. Kordower JH, Rosenstein JM, Collier TJ, Burke MA, Chen EY, Li JM, et al. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol. 1996;370(2):203-30.
69. McKay RD. Stem cell biology and neurodegenerative disease. Philos Trans R Soc Lond B Biol Sci. 2004;359(1445):851-6.
70. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, et al., Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA. 2006;103 (46):17438-43.
71. Noguchi H. Stem cells for the treatment of diabetes. Endocr J. 2007;54(1):7-16.
72. Herrmann WA, Muecke M, Koller M, Gabel VP, Lohmann CP. Keratocyte density in the retroablation area after LASEK for the correction of myopia. Graefes Arch Clin Exp Ophthalmol. 2007; 245 (3):426-30.
73. Baratz KH, Nau CB, Winter EJ, McLaren JW, Hodge DO, Herman DC, et al. Effects of glaucoma medications on corneal endothelium, keratocytes, and subbasal nerves among participants in the ocular hypertension treatment study. Cornea. 2006;25 (9):1046-52.
74. Mollura DJ, Hare JM, Rabb H. Stem-cell therapy for renal diseases. Am J Kidney Dis. 2003;42(5):891-905.
75. Neuringer IP, Randell SH. Stem cells and repair of lung injuries. Respir Res. 2004;5:6.
76. Perillo A, Bonanno G, Pierelli L, Rutella S, Scambia G, Mancuso S. Stem cells in gynecology and obstetrics. Panminerva Med. 2004; 46 (1):49-59.
77. Perillo A, Pierelli L, Scambia G, Leone G, Mancuso S. The role of hematopoietic stem cells in the treatment of ovarian cancer. Panminerva Med. 2002;44(3):197-204.
78. Bianchi DW. Fetal cells in the mother: From genetic diagnosis to diseases associated with fetal cell microchimerism. Eur J Obstet Gynecol Reprod Biol. 2000;92(1):103-8.
79. Bianchi DW. Fetomaternal cell trafficking: A new cause of disease? Am J Med Genet. 2000;91(1):22-8.
80. Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007;13(6):1299-312.
81. Nie X, Zhang JY, Cai KJ, Yang MH, Xiao AH, Da Hu H, et al. Cosmetic improvement in various acute skin defects treated with tissue-engineered skin. Artif Organs. 2007;31(9):703-10.
82. Cheung AM, Kwong YL, Liang R, Leung AY. Stem cell model of hematopoiesis. Curr Stem Cell Res Ther. 2006;1(3):305-15.
83. http://www.ClinicalTrials.gov.
84. García JM, Español T, Gurbindo MD, Casas C C. Update on the treatment of primary immunodeficiencies. Allergol Immunopathol (Madr). 2007;35(5):184-92.
85. Notarangelo LD, Forino C, Mazzolari E. Stem cell transplantation in primary immunodeficiencies. Curr Opin Allergy Clin Immunol. 2006 Dec;6(6):443-8.
86. Choi JS, Lee SH, Chung SJ, Yoo KH, Sung KW, Koo HH. Assessment of converting from intravenous to oral administration of cyclosporin A in pediatric allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2006; 38 (1):29-35.
87. Jakubowski AA, Small TN, Young JW, Kernan NA, Castro-Malaspina H, Hsu KC, et al. T cell depleted stem-cell transplantation for adults with hematologic malignancies: Sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood. 2007;110(13):4552-9.
88. Kim I, Lee KH, Choi Y, Keam B, Koo NH, Yoon SS, et al. Allogeneic stem cell transplantation for patients with advanced hematological malignancies: Comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning. J Korean Med Sci. 2007;22(2):227-34.
89. Jaing TH, Yang CP, Hung IJ, Chen SH, Sun CF, Chow R. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant. 2007;40(4):307-11.
90. Kelly PF, Radtke S, von Kalle C, Balcik B, Bohn K, Mueller R, et al. Stem cell collection and gene transfer in Fanconi anemia. Mol Ther. 2007;15(1):211-9.
91. Laport GG, Sandmaier BM, Storer BE, Scott BL, Stuart MJ, Lange T, et al. Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. Biol Blood Marrow Transplant. 2008;14(2):246-55.
92. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007;110(7):2764-7.
93. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25(11):2739-49.
94. Aiuti A, Cassani B, Andolfi G, Mirolo M, Biasco L, Recchia A, et al. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J Clin Invest. 2007;117(8):2233-40.